Stay updated on VS-6766 and Everolimus Clinical Trial
Sign up to get notified when there's something new on the VS-6766 and Everolimus Clinical Trial page.

Latest updates to the VS-6766 and Everolimus Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRecruitment status updated to no longer looking for participants, indicating that enrollment has ended. New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was updated to reflect formatting changes on the study details page.SummaryDifference0.4%

- Check18 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5. This represents a minor internal version update with no apparent changes to content or functionality.SummaryDifference0.0%

- Check40 days agoChange DetectedThe Publications section now references the Guo et al. Lancet Oncology 2020 article as the original publication and removes the Erratum entry; version notes indicate an addition (v3.5.4) and a corresponding deletion (v3.5.3).SummaryDifference0.1%

- Check62 days agoChange DetectedThe page metadata revision/version number has been incremented from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded a Lancet Oncology publication citation for the VS-6766 study with an erratum. Removed the old revision note and updated the record to revision v3.5.2 (replacing v3.5.0).SummaryDifference0.1%

- Check98 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to VS-6766 and Everolimus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VS-6766 and Everolimus Clinical Trial page.